Abbott to Develop Rapid Test for Orthopedic Infections

Abbott, a healthcare company focused on the development, manufacturing and marketing of pharmaceuticals and medical products, will collaborate with Genetics Laboratory on developing a diagnostic test designed to rapidly detect microorganisms that cause orthopedic infections.

According to The New England Journal of Medicine, approximately 800,000 knee and hip replacement procedures are performed annually in the United States, and complications related to infections occur in approximately 2 percent of those procedures.

 



Under terms of the agreement, Abbott and GenLab will develop and commercialize the new assay for use on the PLEX-ID automated microbial identification system. In the United States, PLEX-ID is currently intended only for non-diagnostic use, but assays are now being developed for future clinical diagnostic uses. PLEX-ID is capable of generating diagnostic results within five to six hours, compared to other methods that may take several days.

Related Articles on Infections:

Kansas Hospitals Reduce Bloodstream Infections by 38%
Banner Hospitals Implement Patient Emergency Hotline to Increase Safety, Satisfaction
California Healthcare Institute Report Spotlights Need for Antibiotics Research

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>